Do's And Don’ts: GMP Risk Assessments For Cross Contamination Between Products.

Add bookmark
Cross contamination within drug production is of prime focus, with potential consequences for patients and workers. (1) As mentioned by Fierce Markets Custom Publishing, one tactic to maintain costs with manufacturing production lines is to process them in parallel. However, especially when the lines process conflicting active pharmaceutical ingredients, there is an increased chance of cross contamination between lines.  This could be airborne, via worker’s garments or by contaminated equip...

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended